Another solid announcement keep them coming SI - in years to come we'll look back at today's prices and will be in awe !!!!
- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel Controlled Study in Crohns & Ulcerative Colitis
MSB
mesoblast limited
Add to My Watchlist
2.69%
!
$1.72

Ann: Remestemcel Controlled Study in Crohns & Ulcerative Colitis, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.72 |
Change
0.045(2.69%) |
Mkt cap ! $2.204B |
Open | High | Low | Value | Volume |
$1.67 | $1.74 | $1.67 | $2.952M | 1.722M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 34457 | $1.71 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.72 | 6290 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
33 | 40606 | 1.720 |
25 | 50264 | 1.715 |
12 | 41461 | 1.710 |
16 | 110617 | 1.705 |
11 | 122029 | 1.700 |
Price($) | Vol. | No. |
---|---|---|
1.725 | 15053 | 18 |
1.730 | 85816 | 25 |
1.735 | 102588 | 15 |
1.740 | 105438 | 14 |
1.745 | 37155 | 7 |
Last trade - 12.07pm 15/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online